North America Nutraceutical Excipients Market
Taille du marché en milliards USD
TCAC :
% 
 Période de prévision |
2023 –2030 |
 Taille du marché (année de référence) |
|
 Taille du marché (année de prévision) |
Dollars américains 2,268.88 |
 TCAC |
% |
| Principaux acteurs du marché |
>Marché des excipients nutraceutiques en Amérique du Nord, par type (agents aromatisants, colorants, édulcorants, agents d'enrobage, tampons, solvants, supports, antimousses, agents de glissement, agents mouillants, épaississants/gélifiants, conservateurs, liants, désintégrants, lubrifiants, charges et diluants et autres), produit final (prébiotiques, probiotiques , suppléments de protéines et d'acides aminés, suppléments minéraux, suppléments vitaminiques, suppléments d'oméga-3 et autres suppléments), forme (sec et liquide), source d'excipient (naturel et synthétique), canal de distribution (appel d'offres direct, vente au détail et autres) - Tendances et prévisions de l'industrie jusqu'en 2030.
Analyse et taille du marché des excipients nutraceutiques en Amérique du Nord
Les excipients nutraceutiques jouent un rôle majeur dans la formulation et le développement des médicaments. Ces substances sont constituées d'autres substances que le médicament ou le promédicament pharmacologiquement actif. Les excipients nutraceutiques permettent au médicament de se libérer efficacement jusqu'au site cible. Ces molécules empêchent la libération trop précoce du médicament lors de son assimilation et améliorent son efficacité. Certains excipients nutraceutiques favorisent l'intégration du médicament, ce qui stimule son absorption dans la circulation sanguine.
Data Bridge Market Research analyse que le marché nord-américain des excipients nutraceutiques devrait atteindre la valeur de 2 268,88 millions USD d'ici 2030, à un TCAC de 8,0 % au cours de la période de prévision. Les liants représentent le segment le plus important du marché en raison de la demande rapide à l'échelle mondiale. Ce rapport de marché couvre également en profondeur l'analyse des prix, l'analyse des brevets et les avancées technologiques.
|
Rapport métrique |
Détails |
|
Période de prévision |
2023 à 2030 |
|
Année de base |
2022 |
|
Années historiques |
2021 (personnalisable pour 2020-2015) |
|
Unités quantitatives |
Chiffre d'affaires en millions USD, volumes en unités, prix en USD |
|
Segments couverts |
Par type (agents aromatisants, colorants, édulcorants , agents d'enrobage, tampons, solvants, supports, antimousses, agents de glissement, agents mouillants, épaississants/gélifiants, conservateurs, liants, désintégrants, lubrifiants, charges et diluants et autres), produit final (prébiotiques, probiotiques, suppléments de protéines et d'acides aminés, suppléments minéraux , suppléments vitaminiques, suppléments d'oméga-3 et autres suppléments), forme (sec et liquide), source d'excipient (naturel et synthétique), canal de distribution (offre directe, vente au détail et autres) |
|
Pays couverts |
États-Unis, Canada, Mexique |
|
Acteurs du marché couverts |
BASF SE., DuPont, Ingredion Incorporated, WR Grace and Co, Kerry Group, Sensient Technologies, Roquette Pharma Solutions, Cargill, Ashland. SEPPIC, Gatefosse, Pioma Chemicals, Omya., Gangwal Chemicals Private Limited, Grain Processing Corporation, IMCD Group., JRS Pharma LP, Azelis, Jigs Chemical, Sigaichi Industries, Beneo et Abitec, entre autres. |
Définition du marché
Nutraceutical excipients involve everything in a drug except the active nutraceutical ingredients. These molecules don’t possess any medicinal properties and are ultimately used for enhancing the physiological absorption of the drug. Nutraceutical excipients are inert in nature, allowing the drug molecule to apply to patients in the right form. Traditionally, nutraceutical excipients were simple molecules, but the innovation in technology and increasing demand for novel drug delivery systems enhanced the nutraceutical excipients' complexity. Nutraceutical excipients promote the patient’s drug acceptability and boost the drug's stability and bioavailability.
The future of excipients science and technology has changed and continues to change. Better progress has been made in such areas as the harmonization of excipient monographs and the application of new analytical methods to better characterize excipients.
North America Nutraceutical Excipients Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail below:
Drivers
- INCREASING AWARENESS REGARDING NUTRACEUTICAL APPLICATIONS
Nutraceutical is derived from nutritional and pharmaceutical. Nutraceutical excipients, also known as ‘functional foods,’ are inactive components prepared with Active Pharmaceutical Ingredients (API) for bulking up solutions with powerful active ingredients. These nutraceutical excipients are used in standardized and pharmaceutical-grade supplements. The skyrocketing increase in medical costs has, affected the nutraceutical excipient market significantly. Excipients are inert substances, other than active drugs, introduced into the manufacturing process or included in the dosage form of nutraceutical products. Excipients are widely used in drug formulations to add bulk to solid formulations, provide long-term stability and facilitate drug absorption. Furthermore, it also improves the overall safety and functional properties of the product during use or storage. The large and diversified application of excipients has made them a very common household name.
Thus, wide applications of nutraceuticals in chronic disease treatment are surging demand for excipients in the North America nutraceutical excipients market.
- TECHNOLOGICAL ADVANCEMENTS IN MULTIFUNCTIONAL EXCIPIENTS
Multifunctional excipients are a class of excipients that includes pre-processed and co-processed excipients that provide added functionalities to the formulation. The enhanced functionality includes flowability, compressibility, particle size distribution, shape and porosity, among others.
The recent interest in demanding manufacturing processes and the focus on alternative delivery systems has led to increased demand for a range of specialty excipients collectively known as multifunctional excipients. The nanotechnology-enabled drug delivery systems are used to cater to the issue of drug toxicity. There are two major approaches to using nanotechnology as a drug delivery system, such as reducing the size of nutraceutical drug crystals to ensure enhanced solubility and bioavailability and using some form of nano-carrier for effective delivery of active ingredients.
Restraint
- Increasing Regulatory Stringency Regarding the Approval of Drugs and Excipients
Generic drug approval rules are largely the same worldwide, with little difference in developing countries. Governments must ensure the consistent quality of all generic drugs. A major reason for physicians' (and even patients') lack of confidence in generic drugs has been the lack of strict regulatory requirements regarding the number of generic drugs and the number of impurities allowed.
Thus, a rise in regulatory stringency regarding the approval of excipients and drugs is expected to restrain the North America nutraceutical excipients market.
Opportunity
-
Increasing demands for alternative routes of delivery and dosage forms
Nutraceuticals are derived from the words nutritional and pharmaceutical. Nutraceutical excipients are inactive components prepared with Active Pharmaceutical Ingredients (API) for bulking up solutions containing potent active ingredients. These nutraceutical excipients are found in supplements that are standardized and pharmaceutical grade.
The development of new treatments or preventive supplements like nutraceuticals for chronic diseases, increased access to medication through generic drug production and increased research and development spending is the major factor for which the alternative routes are a boost.
The advancement in the novel drug delivery system (NDDS) and alternative dosage formulation and route of administration are expected to increase the demand for the new excipient and act as an opportunity for market growth.
Challenge
- Associated Side effects with nutraceutical excipients:
Most of the nutraceuticals contain excipients. They are added for several purposes. They can improve product performance, including enabling formulations, the patient's acceptance and compliance, or providing a more effective and safe drug, such as modified release formulations or taste-masked syrups for children.
Nutraceutical Excipients are not always the inert substances that we presume. They are intolerant to an individual or, if not properly screened, can cause chemical changes in the drug, causing the side-effect. This can affect the demand for the excipient and is expected to act as a challenge for the market.
Post-COVID-19 Impact on the North America Nutraceutical Excipients Market
The nutraceutical industry has been severely affected by the COVID-19 pandemic. Lockdowns imposed due to the epidemic have disrupted the supply of raw materials from manufacturing centers such as India and China. This slowed drug development and production, severely affecting companies that relied heavily on outsourcing. Initially, the entire nutraceutical ecosystem was disrupted. In addition, regulatory agencies had to draft and draft new laws to ensure maximum patient safety after using drugs. After the shutdowns ended, the nutraceutical industry gained steam, especially due to the demand for drugs such as hydroxychloroquine and Remdesivir, which showed positive results against COVID-19. The growing demand for these drugs boosted the turnover of some companies.
Recent Developments
- In February 2022, Kerry Group Plc., the world’s leading taste and Nutrition Company, announced that it had made two significant biotechnology acquisitions that have expanded its expertise, technology portfolio and manufacturing capabilities. The company has announced that it has acquired the leading biotechnology Innovation Company, c-LEcta and Mexican-based enzyme manufacturer, Enmex. c-LEcta is a leading biotechnology innovation company specializing in precision fermentation, optimized bio-processing and bio-transformation. Also, Enmex is a well-established enzyme manufacturer based in Mexico, supplying multiple bio-process solutions for food, beverage and animal nutrition markets. This has helped the company to increase its revenue
- In September 2022, DFE Pharma, a North America leader in pharma- and nutraceutical excipient solutions, opened its new “Closer to the Formulator” (C2F), a Center of Excellence, in Hyderabad, India. C2F helped pharmaceutical companies to shorten the time from concept to finished commercial product through its expertise in all phases of pharmaceutical development. This has helped the company to showcase its progress
North America Nutraceutical Excipients Market Scope
The North America nutraceutical excipients market is segmented into type, end products, form, excipient source and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE
- BINDERS
- FILLERS AND DILUENTS
- DISINTEGRANTS
- COATING MATERIAL
- COLORING AGENTS
- FLAVORING AGENTS
- SWEETENERS
- LUBRICANTS
- BUFFERS
- PRESERVATIVES
- THICKENERS/GELLING AGENTS
- WETTING AGENTS
- GLIDING AGENTS
- SOLVENTS
- CARRIERS
- ANTIFOAMS
- OTHERS
On the basis of type, the North America nutraceutical excipients market is segmented into Flavoring Agents, Coloring Agents, Sweeteners, Coating Agent, Buffers, Solvents, Carriers, Antifoams, Gliding Agents, Wetting Agents, Thickeners/ Gelling Agents, Preservatives, Binders, Disintegrates, Lubricants, Fillers and Diluents and others.
NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCTS
- BINDERS
- FILLERS AND DILUENTS
- DISINTEGRATES
- COATING MATERIAL
- COLORING AGENTS
- FLAVORING AGENTS
- SWEETENERS
- LUBRICANTS
- BUFFERS
- PRESERVATIVES
- THICKENERS/GELLING AGENTS
- WETTING AGENTS
- GLIDING AGENTS
- SOLVENTS
- CARRIERS
- ANTIFOAMS
- OTHERS
On the basis of end products, the North America nutraceutical excipients market is segmented into prebiotics by excipients, probiotics by excipients, protein and amino acid supplements by excipients, mineral supplements by excipients, vitamin supplements, omega-3 supplements by excipients and other supplements.
NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM
- DRY
- LIQUID
On the basis of form, the North America nutraceutical excipients market is segmented into dry and liquid.
NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENT SOURCE
- NATURAL
- SYNTHETIC
On the basis of excipients source, the North America nutraceutical excipients market is segmented into natural and synthetic.
NORTH AMERICA PHARMACEUTICAL EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL
- DIRECT TENDER
- RETAIL SALES
- OTHERS
On the basis of distribution channel, the North America nutraceutical excipients market is segmented into direct tender, retail sales and others.
North America Nutraceutical Excipients Market Regional Analysis/Insights
The North America nutraceutical excipients market is analyzed and market size information is provided type, end products, form, excipient source and distribution channel.
The countries covered in this market report are U.S., Canada, Mexico.
The U.S. is dominating due to the presence of key market players in the largest consumer market with high GDP. It is expected to grow due to the rise in technological advancement in healthcare IT.
The country section of the report also provides individual market-impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, and the impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and North America Nutraceutical Excipients Market Share Analysis
North America nutraceutical excipients market competitive landscape provides details by the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus on the North America nutraceutical excipients market.
Français Certains des principaux acteurs opérant sur le marché des excipients nutraceutiques en Amérique du Nord sont BASF SE., DuPont, Ingredion Incorporated, WR Grace and Co, Kerry Group, Sensient Technologies, Roquette Pharma Solutions, Cargill, Ashland. SEPPIC, Gatefosse, Pioma Chemicals, Omya., Gangwal Chemicals Private Limited, Grain Processing Corporation, IMCD Group., JRS Pharma LP, Azelis, Jigs Chemical, Sigaichi Industries, Beneo et Abitec, entre autres.
SKU-
Accédez en ligne au rapport sur le premier cloud mondial de veille économique
- Tableau de bord d'analyse de données interactif
- Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
- Accès d'analyste de recherche pour la personnalisation et les requêtes
- Analyse de la concurrence avec tableau de bord interactif
- Dernières actualités, mises à jour et analyse des tendances
- Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Table des matières
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 ORIGIN LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHT
4.1 FUTURE PERSPECTIVE ON THE NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET
4.2 SUPPLY CHAIN
4.2.1 RAW MATERIAL PROCUREMENT
4.2.2 MANUFACTURING
4.2.3 MARKETING & DISTRIBUTION
4.2.4 END USERS
4.2.5 LOGISTIC COST SCENARIO
4.2.6 IMPORTANCE OF LOGISTIC SERVICE PROVIDER
4.3 VALUE CHAIN ANALYSIS
5 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET, REGULATIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING AWARENESS REGARDING NUTRACEUTICAL APPLICATIONS
6.1.2 TECHNOLOGICAL ADVANCEMENTS IN MULTIFUNCTIONAL EXCIPIENTS
6.1.3 RISE IN NUTRACEUTICAL DRUG PRODUCTION AND USES
6.1.4 INCREASING PREVALENCE OF LIFESTYLE DISEASES AND CHRONIC HEART DISEASES
6.2 RESTRAINTS
6.2.1 INCREASING REGULATORY STRINGENCY REGARDING THE APPROVAL OF DRUGS AND EXCIPIENTS
6.2.2 HIGH PRODUCTION COST
6.3 OPPORTUNITIES
6.3.1 INCREASING DEMANDS FOR ALTERNATIVE ROUTES OF DELIVERY AND DOSAGE FORMS
6.3.2 RISE IN DEMAND FOR MULTIFUNCTIONAL EXCIPIENTS
6.3.3 RISING DISPOSABLE INCOME
6.4 CHALLENGES
6.4.1 ASSOCIATED SIDE EFFECTS WITH NUTRACEUTICAL EXCIPIENTS:
6.4.2 SAFETY CONSIDERATION OF NUTRACEUTICAL EXCIPIENTS IN STORAGE AND TRANSPORTATION
7 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE
7.1 OVERVIEW
7.2 BINDERS
7.2.1 SYNTHETIC/ SEMISYNTHETIC
7.2.2 NATURAL
7.2.3 HMPC
7.2.4 MCC
7.2.5 HPC
7.3 FILLER AND DILUENTS
7.4 DISINTEGRANTS
7.4.1 BY SYNTHESIS
7.4.1.1 SYNTHETIC/ SEMISYNTHETIC
7.4.1.2 NATURAL
7.4.2 BY TYPE
7.4.2.1 CROSSPOVIDONE
7.4.2.2 CROSCAMELLOSE
7.5 COATING MATERIAL
7.5.1 BY FUNCTIONALITY
7.5.1.1 FUNCTIONAL COATING AGENTS
7.5.1.2 NON-FUNCTIONAL COATING AGENTS
7.5.2 BY COATING TYPE
7.5.2.1 ENTERIC COATING
7.5.2.2 FILM COATING
7.5.2.3 GELATIN COATING
7.5.2.4 SUGAR COATING
7.5.2.5 OTHERS
7.6 COLORING AGENTS
7.6.1 SYNTHETIC COLORING AGENT
7.6.1.1 GREEN S
7.6.1.2 PATENT BLUE V
7.6.1.3 QUINOLINE YELLOW
7.6.1.4 CARMOISINE
7.6.1.5 PONCEAU 4R
7.6.1.6 OTHERS
7.6.2 NATURAL COLORING AGENT
7.6.2.1 PLANT DERIVED
7.6.2.1.1 INDIGO
7.6.2.1.2 BETA-CAROTENE
7.6.2.1.3 PAPRIKA
7.6.2.1.4 TURMERIC
7.6.2.1.5 SAFFRON
7.6.2.1.6 OTHERS
7.6.2.2 ANIMAL DERIVED
7.6.2.2.1 COCHNINEAL EXTRACT
7.6.2.2.2 OTHERS
7.6.2.3 MINERAL DERIVED
7.6.2.3.1 RED FERRIC OXIDE
7.6.2.3.2 TITANIUM OXIDE
7.6.2.3.3 LEAD OXIDE
7.6.2.3.4 COPPER SULPHATE
7.6.2.3.5 CARBON BLACK
7.6.2.3.6 OTHERS
7.7 FLAVORING AGENTS
7.7.1 BY FORM
7.7.1.1 DRY
7.7.1.2 LIQUID
7.7.2 BY TYPE
7.7.2.1 ARTIFICIAL OR SYNTHETIC FLAVORING AGENT
7.7.2.2 NATURAL FLAVORING AGENT
7.8 SWEETENERS
7.8.1 BY SOURCE
7.8.1.1 ARTIFICIAL SWEETENERS
7.8.1.2 NATURAL SWEETENERS
7.8.2 BY CALORIE
7.8.2.1 NUTRITIVE OR CALORIE SWEETENING AGENTS
7.8.2.2 NON-NUTRITIVE OR LOW CALORIE SWEETENING AGENTS
7.9 LUBRICANTS
7.9.1 BY FORM
7.9.1.1 DRY
7.9.1.2 LIQUID
7.9.2 BY SOLUBILITY
7.9.2.1 WATER SOLUBLE
7.9.2.2 WATER INSOLUBLE
7.1 BUFFERS
7.11 PRESERVATIVES
7.11.1 CHEMICAL PRESERVATIVES
7.11.1.1 BENZOATES
7.11.1.2 NITRILES
7.11.1.3 SULPHITES
7.11.1.4 SORBATES
7.11.1.5 OTHERS
7.11.2 ARTIFICIAL PRESERVATIVES
7.11.2.1 ANTIMICROBIAL AGENTS
7.11.2.2 ANTIOXIDANTS
7.11.2.3 CHELATING AGENTS
7.11.2.4 OTHERS
7.11.3 NATURAL PRESERVATIVES
7.12 THICKENERS/ GELLING AGENTS
7.12.1 SODIUM ALGINATE
7.12.2 PROPYLENE GLYCOL
7.12.3 XANTHAN GUM
7.12.4 GUAR GUM
7.12.5 LOCUST BEAN GUM
7.12.6 OTHERS
7.13 WETTING AGENTS
7.13.1 ANIONIC
7.13.2 CATIONIC
7.13.3 AMPHOTERIC
7.13.4 NONIONIC
7.14 GLIDING AGENTS
7.14.1 COLLOIDAL SILICON DIOXIDE
7.14.2 TALC
7.14.3 TRIBASIC CALCIUM PHOSPHATE
7.14.4 CALCIUM SILICATE
7.14.5 MAGNESIUM OXIDE
7.14.6 SODIUM STEARATE
7.14.7 MAGNESIUM SILICATE
7.14.8 SILICA
7.14.9 MAGNESIUM TRISILICATE
7.14.10 HYDROPHOBIC COLLOIDAL SILICA
7.14.11 OTHERS
7.15 SOLVENTS
7.15.1 POLAR
7.15.2 NON POLAR
7.16 CARRIERS
7.17 ANTIFOAMS
7.18 OTHERS
8 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCTS
8.1 OVERVIEW
8.2 PROBIOTICS
8.2.1 BINDERS
8.2.2 FILLERS AND DILUENTS
8.2.3 DISINTEGRANTS
8.2.4 COATING MATERIAL
8.2.5 COLORING AGENTS
8.2.6 FLAVORING AGENTS
8.2.7 SWEETENERS
8.2.8 LUBRICANTS
8.2.9 BUFFERS
8.2.10 PRESERVATIVES
8.2.11 THICKENERS/GELLING AGENTS
8.2.12 WETTING AGENT
8.2.13 GLIDING AGENT
8.2.14 SOLVENTS
8.2.15 CARRIERS
8.2.16 ANTIFOAMS
8.2.17 OTHERS
8.3 PREBIOTICS
8.3.1 BINDERS
8.3.2 FILLERS AND DILUENTS
8.3.3 DISINTEGRANTS
8.3.4 COATING MATERIAL
8.3.5 COLORING AGENTS
8.3.6 FLAVORING AGENTS
8.3.7 SWEETENERS
8.3.8 LUBRICANTS
8.3.9 BUFFERS
8.3.10 PRESERVATIVES
8.3.11 THICKENERS/GELLING AGENTS
8.3.12 WETTING AGENT
8.3.13 GLIDING AGENT
8.3.14 SOLVENTS
8.3.15 CARRIERS
8.3.16 ANTIFOAMS
8.3.17 OTHERS
8.4 PROTEIN AND AMINO ACID SUPPLEMENTS
8.4.1 BINDERS
8.4.2 FILLERS AND DILUENTS
8.4.3 DISINTEGRANTS
8.4.4 COATING MATERIAL
8.4.5 COLORING AGENTS
8.4.6 FLAVORING AGENTS
8.4.7 SWEETENERS
8.4.8 LUBRICANTS
8.4.9 BUFFERS
8.4.10 PRESERVATIVES
8.4.11 THICKENERS/GELLING AGENTS
8.4.12 WETTING AGENT
8.4.13 GLIDING AGENT
8.4.14 SOLVENTS
8.4.15 CARRIERS
8.4.16 ANTIFOAMS
8.4.17 OTHERS
8.5 VITAMIN SUPPLEMENTS
8.5.1 BY TYPE
8.5.1.1 VITAMIN B
8.5.1.1.1 VITAMIN B12
8.5.1.1.2 VITAMIN B6
8.5.1.1.3 VITAMIN B3
8.5.1.1.4 VITAMIN B1
8.5.1.1.5 VITAMIN B2
8.5.1.1.6 OTHERS
8.5.1.2 VITAMIN C
8.5.1.3 VITAMIN D
8.5.1.4 VITAMIN E
8.5.1.5 VITAMIN A
8.5.1.6 OTHERS
8.5.2 BY EXCIPIENTS
8.5.2.1 BINDERS
8.5.2.2 FILLERS AND DILUENTS
8.5.2.3 DISINTEGRANTS
8.5.2.4 COATING MATERIAL
8.5.2.5 COLORING AGENTS
8.5.2.6 FLAVORING AGENTS
8.5.2.7 SWEETENERS
8.5.2.8 LUBRICANTS
8.5.2.9 BUFFERS
8.5.2.10 PRESERVATIVES
8.5.2.11 THICKENERS/GELLING AGENTS
8.5.2.12 WETTING AGENT
8.5.2.13 GLIDING AGENT
8.5.2.14 SOLVENTS
8.5.2.15 CARRIERS
8.5.2.16 ANTIFOAMS
8.5.2.17 OTHERS
8.6 MINERAL SUPPLEMENTS
8.6.1 BINDERS
8.6.2 FILLERS AND DILUENTS
8.6.3 DISINTEGRANTS
8.6.4 COATING MATERIAL
8.6.5 COLORING AGENTS
8.6.6 FLAVORING AGENTS
8.6.7 SWEETENERS
8.6.8 LUBRICANTS
8.6.9 BUFFERS
8.6.10 PRESERVATIVES
8.6.11 THICKENERS/GELLING AGENTS
8.6.12 WETTING AGENT
8.6.13 GLIDING AGENT
8.6.14 SOLVENTS
8.6.15 CARRIERS
8.6.16 ANTIFOAMS
8.6.17 OTHERS
8.7 OMEGA-3 SUPPLEMENTS
8.7.1 BINDERS
8.7.2 FILLERS AND DILUENTS
8.7.3 DISINTEGRANTS
8.7.4 COATING MATERIAL
8.7.5 COLORING AGENTS
8.7.6 FLAVORING AGENTS
8.7.7 SWEETENERS
8.7.8 LUBRICANTS
8.7.9 BUFFERS
8.7.10 PRESERVATIVES
8.7.11 THICKENERS/GELLING AGENTS
8.7.12 WETTING AGENT
8.7.13 GLIDING AGENT
8.7.14 SOLVENTS
8.7.15 CARRIERS
8.7.16 ANTIFOAMS
8.7.17 OTHERS
8.8 OTHER SUPPLEMENTS
8.8.1 BINDERS
8.8.2 FILLERS AND DILUENTS
8.8.3 DISINTEGRANTS
8.8.4 COATING MATERIAL
8.8.5 COLORING AGENTS
8.8.6 FLAVORING AGENTS
8.8.7 SWEETENERS
8.8.8 LUBRICANTS
8.8.9 BUFFERS
8.8.10 PRESERVATIVES
8.8.11 THICKENERS/GELLING AGENTS
8.8.12 WETTING AGENT
8.8.13 GLIDING AGENT
8.8.14 SOLVENTS
8.8.15 CARRIERS
8.8.16 ANTIFOAMS
8.8.17 OTHERS
9 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM
9.1 OVERVIEW
9.2 DRY
9.3 LIQUID
10 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENT SOURCE
10.1 OVERVIEW
10.2 SYNTHETIC
10.3 NATURAL
10.3.1 PLANT
10.3.2 ANIMAL
10.3.3 MINERAL
11 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TENDER
11.3 RETAIL SALES
11.3.1 MASS MERCHANDISE
11.3.2 ONLINE STORES
11.3.3 OTHERS
11.4 OTHERS
12 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION
12.1 NORTH AMERICA
12.1.1 U.S.
12.1.2 CANADA
12.1.3 MEXICO
13 NORTH AMERICA NUTRACEUTICAL EXCIPIENT MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
14 SWOT ANALYSIS
15 COMPANY PROFILE
15.1 INGREDION. (2022)
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENTS
15.2 BASF SE (2022)
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 COMPANY SHARE ANALYSIS
15.2.4 PRODUCT PORTFOLIO
15.2.5 RECENT DEVELOPMENT
15.3 AZELIS (2022)
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 COMPANY SHARE ANALYSIS
15.3.4 PRODUCT PORTFOLIO
15.3.5 RECENT DEVELOPMENT
15.4 CARGILL, INCORPORATED.
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 COMPANY SHARE ANALYSIS
15.4.4 PRODUCT PORTFOLIO
15.4.5 RECENT DEVELOPMENT
15.5 JRS PHARMA
15.5.1 COMPANY SNAPSHOT
15.5.2 COMPANY SHARE ANALYSIS
15.5.3 PRODUCT PORTFOLIO
15.5.4 RECENT DEVELOPMENT
15.6 ABITEC
15.6.1 COMPANY SNAPSHOT
15.6.2 PRODUCT PORTFOLIO
15.6.3 RECENT DEVELOPMENT
15.7 ASHLAND (2022)
15.7.1 COMPANY SNAPSHOT
15.7.2 REVENUE ANALYSIS
15.7.3 PRODUCT PORTFOLIO
15.7.4 RECENT DEVELOPMENT
15.8 BENEO (A SUBSIDIARY OF SUDZUCKER)
15.8.1 COMPANY SNAPSHOT
15.8.2 REVENUE ANALYSIS
15.8.3 PRODUCT PORTFOLIO
15.8.4 RECENT DEVELOPMENT
15.9 DUPONT (A SUBSIDIARY OF DUPONT DE NEMOURS, INC.) (2022)
15.9.1 COMPANY SNAPSHOT
15.9.2 REVENUE ANALYSIS
15.9.3 PRODUCT PORTFOLIO
15.9.4 RECENT DEVELOPMENT
15.1 GANGWAL CHEMICALS PVT. LTD.
15.10.1 COMPANY SNAPSHOT
15.10.2 PRODUCT PORTFOLIO
15.10.3 RECENT DEVELOPMENT
15.11 GATTEFOSSE
15.11.1 COMPANY SNAPSHOT
15.11.2 PRODUCT PORTFOLIO
15.11.3 RECENT DEVELOPMENT
15.12 GRAIN PROCESSING CORPORATION (2022)
15.12.1 COMPANY SNAPSHOT
15.12.2 REVENUE ANALYSIS
15.12.3 PRODUCT PORTFOLIO
15.12.4 RECENT DEVELOPMENT
15.13 IMCD (2022)
15.13.1 COMPANY SNAPSHOT
15.13.2 REVENUE ANALYSIS
15.13.3 PRODUCT PORTFOLIO
15.13.4 RECENT DEVELOPMENT
15.14 JIGS CHEMICAL
15.14.1 COMPANY SNAPSHOT
15.14.2 PRODUCT PORTFOLIO
15.14.3 RECENT DEVELOPMENT
15.15 KERRY GROUP PLC.
15.15.1 COMPANY SNAPSHOT
15.15.2 REVENUE ANALYSIS
15.15.3 PRODUCT PORTFOLIO
15.15.4 RECENT DEVELOPMENT
15.16 OMYA
15.16.1 COMPANY SNAPSHOT
15.16.2 PRODUCT PORTFOLIO
15.16.3 RECENT DEVELOPMENT
15.17 PIOMA CHEMICALS
15.17.1 COMPANY SNAPSHOT
15.17.2 PRODUCT PORTFOLIO
15.17.3 RECENT DEVELOPMENT
15.18 ROQUETTE FRÈRES
15.18.1 COMPANY SNAPSHOT
15.18.2 PRODUCT PORTFOLIO
15.18.3 RECENT DEVELOPMENTS
15.19 SENSIENT TECHNOLOGIES CORPORATION (2022)
15.19.1 COMPANY SNAPSHOT
15.19.2 REVENUE ANALYSIS
15.19.3 PRODUCT PORTFOLIO
15.19.4 RECENT DEVELOPMENT
15.2 SEPPIC
15.20.1 COMPANY SNAPSHOT
15.20.2 PRODUCT PORTFOLIO
15.20.3 RECENT DEVELOPMENT
15.21 SIGACHI INDUSTRIES (2022)
15.21.1 COMPANY SNAPSHOT
15.21.2 REVENUE ANALYSIS
15.21.3 PRODUCT PORTFOLIO
15.21.4 RECENT DEVELOPMENT
15.22 W.R. GRACE & CO.-CONN
15.22.1 COMPANY SNAPSHOT
15.22.2 PRODUCT PORTFOLIO
15.22.3 RECENT DEVELOPMENT
16 QUESTIONNAIRE
17 RELATED REPORTS
Liste des tableaux
TABLE 1 THIS GUIDELINE REQUIRES MARKETING AUTHORIZATION HOLDERS TO DISPLAY EXCIPIENTS IN THE FOLLOWING WAYS:
TABLE 2 APPLICATIONS OF NUTRACEUTICALS
TABLE 3 NUTRACEUTICAL DRUG PRODUCTS
TABLE 4 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 5 NORTH AMERICA BINDERS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 6 NORTH AMERICA BINDERS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 7 NORTH AMERICA FILLER AND DILUENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 8 NORTH AMERICA DISINTEGRANTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 9 NORTH AMERICA DISINTEGRANTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY SYNTHESIS, 2021-2030 (USD MILLION)
TABLE 10 NORTH AMERICA DISINTEGRANTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 11 NORTH AMERICA COATING MATERIAL IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 12 NORTH AMERICA COATING MATERIAL IN NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021-2030 (USD MILLION)
TABLE 13 NORTH AMERICA COATING MATERIAL IN NUTRACEUTICAL EXCIPIENTS MARKET, BY COATING TYPE, 2021-2030 (USD MILLION)
TABLE 14 NORTH AMERICA COLORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 15 NORTH AMERICA COLORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 16 NORTH AMERICA SYNTHETIC COLORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 17 NORTH AMERICA NATURAL COLORING AGENT IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 18 NORTH AMERICA PLANT DERIVED IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 19 NORTH AMERICA ANIMAL DERIVED IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 20 NORTH AMERICA MINERAL DERIVED IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 21 NORTH AMERICA FLAVORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 22 NORTH AMERICA FLAVORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM, 2021-2030 (USD MILLION)
TABLE 23 NORTH AMERICA FLAVORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 24 NORTH AMERICA SWEETENERS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 25 NORTH AMERICA SWEETENERS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 26 NORTH AMERICA SWEETENERS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY CALORIE, 2021-2030 (USD MILLION)
TABLE 27 NORTH AMERICA LUBRICANTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 28 NORTH AMERICA LUBRICANTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM, 2021-2030 (USD MILLION)
TABLE 29 NORTH AMERICA LUBRICANTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY SOLUBILITY, 2021-2030 (USD MILLION)
TABLE 30 NORTH AMERICA BUFFERS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 31 NORTH AMERICA PRESERVATIVES IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 32 NORTH AMERICA PRESERVATIVES IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 33 NORTH AMERICA CHEMICAL PRESERVATIVES IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 34 NORTH AMERICA ARTIFICIAL PRESERVATIVES IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 35 NORTH AMERICA THICKENERS/ GELLING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 36 NORTH AMERICA THICKENERS/ GELLING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 37 NORTH AMERICA WETTING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 38 NORTH AMERICA WETTING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 39 NORTH AMERICA GLIDING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 40 NORTH AMERICA GLIDING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 41 NORTH AMERICA SOLVENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 42 NORTH AMERICA SOLVENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 43 NORTH AMERICA CARRIERS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 44 NORTH AMERICA ANTIFOAMS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 45 NORTH AMERICA OTHERS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 46 NORTH AMERICA NUTRACEUTICAL EXCIPIENT MARKET, BY END PRODUCTS, 2021-2030 (USD MILLION)
TABLE 47 NORTH AMERICA PROBIOTICS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 48 NORTH AMERICA PROBIOTICS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 49 NORTH AMERICA PREBIOTICS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 50 NORTH AMERICA PREBIOTICS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 51 NORTH AMERICA PROTEIN AND AMINO ACID SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 52 NORTH AMERICA PROTEIN AND AMINO ACID SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 53 NORTH AMERICA VITAMIN SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 54 NORTH AMERICA VITAMIN SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 55 NORTH AMERICA VITAMIN B IN NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 56 NORTH AMERICA VITAMIN SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 57 NORTH AMERICA MINERAL SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 58 NORTH AMERICA MINERAL SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 59 NORTH AMERICA OMEGA-3 SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 60 NORTH AMERICA OMEGA-3 SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 61 NORTH AMERICA OTHER SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 62 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM, 2021-2030 (USD MILLION)
TABLE 63 NORTH AMERICA DRY IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 64 NORTH AMERICA LIQUID IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 65 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENT SOURCE, 2021-2030 (USD MILLION)
TABLE 66 NORTH AMERICA SYNTHETIC IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 67 NORTH AMERICA NATURAL IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 68 NORTH AMERICA NATURAL IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENT SOURCE, 2021-2030 (USD MILLION)
TABLE 69 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 70 NORTH AMERICA DIRECT TENDER IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 71 NORTH AMERICA RETAIL SALES IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 72 NORTH AMERICA RETAIL SALES IN NUTRACEUTICAL EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 73 NORTH AMERICA OTHERS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 74 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 75 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 76 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 77 NORTH AMERICA BINDERS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 78 NORTH AMERICA DISINTEGRANTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY SYNTHESIS, 2021-2030 (USD MILLION)
TABLE 79 NORTH AMERICA DISINTEGRANTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 80 NORTH AMERICA COATING MATERIAL IN NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021-2030 (USD MILLION)
TABLE 81 NORTH AMERICA COATING MATERIAL IN NUTRACEUTICAL EXCIPIENTS MARKET, BY COATING TYPE, 2021-2030 (USD MILLION)
TABLE 82 NORTH AMERICA COLORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 83 NORTH AMERICA SYNTHETIC COLORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 84 NORTH AMERICA NATURAL COLORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 85 NORTH AMERICA PLANT DERIVED IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 86 NORTH AMERICA ANIMAL DERIVED IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 87 NORTH AMERICA MINERAL DERIVED IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 88 NORTH AMERICA FLAVORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM, 2021-2030 (USD MILLION)
TABLE 89 NORTH AMERICA FLAVORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 90 NORTH AMERICA SWEETENERS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 91 NORTH AMERICA SWEETENERS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY CALORIE, 2021-2030 (USD MILLION)
TABLE 92 NORTH AMERICA LUBRICANTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM, 2021-2030 (USD MILLION)
TABLE 93 NORTH AMERICA LUBRICANTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY SOLUBILITY, 2021-2030 (USD MILLION)
TABLE 94 NORTH AMERICA PRESERVATIVES IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 95 NORTH AMERICA CHEMICAL PRESERVATIVES IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 96 NORTH AMERICA ARTIFICIAL PRESERVATIVES IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 97 NORTH AMERICA THICKENER AND GELLING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 98 NORTH AMERICA WETTING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 99 NORTH AMERICA GLIDING AGENTS IN NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 100 NORTH AMERICA SOLVENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 101 NORTH AMERICA NUTRACEUTICAL EXCIPIENT MARKET, BY END PRODUCTS, 2021-2030 (USD MILLION)
TABLE 102 NORTH AMERICA PROBIOTICS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 103 NORTH AMERICA PREBIOTICS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 104 NORTH AMERICA PROTEIN AND AMINO ACID SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 105 NORTH AMERICA VITAMIN SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 106 NORTH AMERICA VITAMIN B IN NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 107 NORTH AMERICA VITAMIN SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 108 NORTH AMERICA MINERAL SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 109 NORTH AMERICA OMEGA-3 SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 110 NORTH AMERICA OTHERS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 111 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM, 2021-2030 (USD MILLION)
TABLE 112 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENT SOURCE, 2021-2030 (USD MILLION)
TABLE 113 NORTH AMERICA NATURAL IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENT SOURCE, 2021-2030 (USD MILLION)
TABLE 114 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 115 NORTH AMERICA RETAIL SALES IN NUTRACEUTICAL EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 116 U.S. NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 117 U.S. NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 118 U.S. NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCTS, 2021-2030, (ASP)
TABLE 119 U.S. BINDERS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 120 U.S. DISINTEGRATES IN NUTRACEUTICAL EXCIPIENTS MARKET, BY SYNTHESIS, 2021-2030 (USD MILLION)
TABLE 121 U.S. DISINTEGRATES IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 122 U.S. COATING MATERIAL IN NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021-2030 (USD MILLION)
TABLE 123 U.S. COATING MATERIAL IN NUTRACEUTICAL EXCIPIENTS MARKET, BY COATING TYPE, 2021-2030 (USD MILLION)
TABLE 124 U.S. COLORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 125 U.S. SYNTHETIC COLORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 126 U.S. NATURAL COLORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 127 U.S. PLANT DERIVED IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 128 U.S. ANIMAL DERIVED IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 129 U.S. MINERAL DERIVED IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 130 U.S. FLAVORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM, 2021-2030 (USD MILLION)
TABLE 131 U.S. FLAVORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 132 U.S. SWEETENERS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 133 U.S. SWEETENERS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY CALORIE, 2021-2030 (USD MILLION)
TABLE 134 U.S. LUBRICANTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM, 2021-2030 (USD MILLION)
TABLE 135 U.S. LUBRICANTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY SOLUBILITY, 2021-2030 (USD MILLION)
TABLE 136 U.S. PRESERVATIVES IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 137 U.S. CHEMICAL PRESERVATIVES IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 138 U.S. ARTIFICIAL PRESERVATIVES IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 139 U.S. THICKENER AND GELLING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 140 U.S. WETTING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 141 U.S. GLIDING AGENTS IN NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 142 U.S. SOLVENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 143 U.S. NUTRACEUTICAL EXCIPIENT MARKET, BY END PRODUCTS, 2021-2030 (USD MILLION)
TABLE 144 U.S. PROBIOTICS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 145 U.S. PREBIOTICS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 146 U.S. PROTEIN AND AMINO ACID SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 147 U.S. VITAMIN SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 148 U.S. VITAMIN B IN NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 149 U.S. VITAMIN SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 150 U.S. MINERAL SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 151 U.S. OMEGA-3 SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 152 U.S. OTHERS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 153 U.S. NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM, 2021-2030 (USD MILLION)
TABLE 154 U.S. NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENT SOURCE, 2021-2030 (USD MILLION)
TABLE 155 U.S NATURAL IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENT SOURCE, 2021-2030 (USD MILLION)
TABLE 156 U.S. NUTRACEUTICAL EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 157 U.S. RETAIL SALES IN NUTRACEUTICAL EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 158 CANADA NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 159 CANADA NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 160 CANADA NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCTS, 2021-2030, (ASP)
TABLE 161 CANADA BINDERS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 162 CANADA DISINTEGRANTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY SYNTHESIS, 2021-2030 (USD MILLION)
TABLE 163 CANADA DISINTEGRANTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 164 CANADA COATING MATERIAL IN NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021-2030 (USD MILLION)
TABLE 165 CANADA COATING MATERIAL IN NUTRACEUTICAL EXCIPIENTS MARKET, BY COATING TYPE, 2021-2030 (USD MILLION)
TABLE 166 CANADA COLORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 167 CANADA SYNTHETIC COLORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 168 CANADA NATURAL COLORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 169 CANADA PLANT DERIVED IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 170 CANADA ANIMAL DERIVED IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 171 CANADA MINERAL DERIVED IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 172 CANADA FLAVORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM, 2021-2030 (USD MILLION)
TABLE 173 CANADA FLAVORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 174 CANADA SWEETENERS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 175 CANADA SWEETENERS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY CALORIE, 2021-2030 (USD MILLION)
TABLE 176 CANADA LUBRICANTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM, 2021-2030 (USD MILLION)
TABLE 177 CANADA LUBRICANTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY SOLUBILITY, 2021-2030 (USD MILLION)
TABLE 178 CANADA PRESERVATIVES IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 179 CANADA CHEMICAL PRESERVATIVES IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 180 CANADA ARTIFICIAL PRESERVATIVES IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 181 CANADA THICKENER AND GELLING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 182 CANADA WETTING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 183 CANADA GLIDING AGENTS IN NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 184 CANADA SOLVENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 185 CANADA NUTRACEUTICAL EXCIPIENT MARKET, BY END PRODUCTS, 2021-2030 (USD MILLION)
TABLE 186 CANADA PROBIOTICS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 187 CANADA PREBIOTICS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 188 CANADA PROTEIN AND AMINO ACID SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 189 CANADA VITAMIN SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 190 CANADA VITAMIN B IN NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 191 CANADA VITAMIN SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 192 CANADA MINERAL SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 193 CANADA OMEGA-3 SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 194 CANADA OTHERS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 195 CANADA NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM, 2021-2030 (USD MILLION)
TABLE 196 CANADA NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENT SOURCE, 2021-2030 (USD MILLION)
TABLE 197 CANADA NATURAL IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENT SOURCE, 2021-2030 (USD MILLION)
TABLE 198 CANADA NUTRACEUTICAL EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 199 CANADA RETAIL SALES IN NUTRACEUTICAL EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 200 MEXICO NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 201 MEXICO NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS)
TABLE 202 MEXICO NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCTS, 2021-2030, (ASP)
TABLE 203 MEXICO BINDERS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 204 MEXICO DISINTEGRANTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY SYNTHESIS, 2021-2030 (USD MILLION)
TABLE 205 MEXICO DISINTEGRANTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 206 MEXICO COATING MATERIAL IN NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021-2030 (USD MILLION)
TABLE 207 MEXICO COATING MATERIAL IN NUTRACEUTICAL EXCIPIENTS MARKET, BY COATING TYPE, 2021-2030 (USD MILLION)
TABLE 208 MEXICO COLORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 209 MEXICO SYNTHETIC COLORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 210 MEXICO NATURAL COLORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 211 MEXICO PLANT DERIVED IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 212 MEXICO ANIMAL DERIVED IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 213 MEXICO MINERAL DERIVED IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 214 MEXICO FLAVORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM, 2021-2030 (USD MILLION)
TABLE 215 MEXICO FLAVORING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 216 MEXICO SWEETENERS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 217 MEXICO SWEETENERS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY CALORIE, 2021-2030 (USD MILLION)
TABLE 218 MEXICO LUBRICANTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM, 2021-2030 (USD MILLION)
TABLE 219 MEXICO LUBRICANTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY SOLUBILITY, 2021-2030 (USD MILLION)
TABLE 220 MEXICO PRESERVATIVES IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 221 MEXICO CHEMICAL PRESERVATIVES IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 222 MEXICO ARTIFICIAL PRESERVATIVES IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 223 MEXICO THICKENER AND GELLING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 224 MEXICO WETTING AGENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 225 MEXICO GLIDING AGENTS IN NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 226 MEXICO SOLVENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 227 MEXICO NUTRACEUTICAL EXCIPIENT MARKET, BY END PRODUCTS, 2021-2030 (USD MILLION)
TABLE 228 MEXICO PROBIOTICS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 229 MEXICO PREBIOTICS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 230 MEXICO PROTEIN AND AMINO ACID SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 231 MEXICO VITAMIN SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 232 MEXICO VITAMIN B IN NUTRACEUTICAL EXCIPIENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 233 MEXICO VITAMIN SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 234 MEXICO MINERAL SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 235 MEXICO OMEGA-3 SUPPLEMENTS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 236 MEXICO OTHERS IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENTS, 2021-2030 (USD MILLION)
TABLE 237 MEXICO NUTRACEUTICAL EXCIPIENTS MARKET, BY FORM, 2021-2030 (USD MILLION)
TABLE 238 MEXICO NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENT SOURCE, 2021-2030 (USD MILLION)
TABLE 239 MEXICO NATURAL IN NUTRACEUTICAL EXCIPIENTS MARKET, BY EXCIPIENT SOURCE, 2021-2030 (USD MILLION)
TABLE 240 MEXICO NUTRACEUTICAL EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 241 MEXICO RETAIL SALES IN NUTRACEUTICAL EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
Liste des figures
FIGURE 1 NORTH AMERICA PHARMACEUTICAL EXCIPIENTS MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: MULTIVARIATE MODELLING
FIGURE 7 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: DBMR MARKET POSITION GRID
FIGURE 9 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 10 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: VENDOR SHARE ANALYSIS
FIGURE 11 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: SEGMENTATION
FIGURE 12 INCREASING AWARENESS REGARDING NUTRACEUTICAL APPLICATIONS IS DRIVING THE NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET IN THE FORECAST PERIOD OF 2023 TO 2030
FIGURE 13 THE BINDERS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET IN 2023 & 2030
FIGURE 14 VALUE CHAIN OF NORTH AMERICA NUTRACEUTICAL EXCIPIENT MARKET
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET
FIGURE 16 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: BY TYPE, 2022
FIGURE 17 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: BY TYPE, 2023-2030 (USD MILLION)
FIGURE 18 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: BY TYPE, CAGR (2023-2030)
FIGURE 19 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: BY TYPE, LIFELINE CURVE
FIGURE 20 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: BY END PRODUCTS, 2022
FIGURE 21 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: BY END PRODUCTS, 2023-2030 (USD MILLION)
FIGURE 22 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: BY END PRODUCTS, CAGR (2023-2030)
FIGURE 23 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: BY END PRODUCTS, LIFELINE CURVE
FIGURE 24 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: BY FORM, 2022
FIGURE 25 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: BY FORM, 2023-2030 (USD MILLION)
FIGURE 26 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: BY FORM, CAGR (2023-2030)
FIGURE 27 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: BY FORM, LIFELINE CURVE
FIGURE 28 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: BY EXCIPIENT SOURCE, 2022
FIGURE 29 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: BY EXCIPIENT SOURCE, 2023-2030 (USD MILLION)
FIGURE 30 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: BY EXCIPIENT SOURCE, CAGR (2023-2030)
FIGURE 31 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: BY EXCIPIENT SOURCE, LIFELINE CURVE
FIGURE 32 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 33 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 34 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 35 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 36 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: SNAPSHOT (2022)
FIGURE 37 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: BY COUNTRY (2022)
FIGURE 38 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: BY COUNTRY (2023 & 2030)
FIGURE 39 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: BY COUNTRY (2022 & 2030)
FIGURE 40 NORTH AMERICA NUTRACEUTICAL EXCIPIENTS MARKET: BY TYPE (2023-2030)
FIGURE 41 NORTH AMERICA NUTRACEUTICAL EXCIPIENT MARKET: COMPANY SHARE 2022 (%)
Méthodologie de recherche
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.
La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.
Personnalisation disponible
Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.
